ArticleOncotarget2016

Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.

Yuan-Zheng Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.